Medicine for treating onychomycosis and preparation method of medicine

A technology of onychomycosis and medicament, which is applied in the field of medicament for treating onychomycosis and its preparation, which can solve the problems of large side effects, easy recurrence, and incomplete treatment of onychomycosis, achieve small side effects, prolong residence time, and improve rheological properties Effect

Inactive Publication Date: 2020-11-06
湖南巨禧医药科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] But the prescription of the onychomycosis treatment technical scheme in the prior art is not thorough to the treatment of onychomycosis, easily recurs, and side effect is big

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating onychomycosis and preparation method of medicine
  • Medicine for treating onychomycosis and preparation method of medicine
  • Medicine for treating onychomycosis and preparation method of medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] A medicine for treating onychomycosis, comprising the following components: 22-25 parts of Salvia miltiorrhiza, 15-27 parts of Fangfeng, 12-16 parts of Baibu, 20-30 parts of Cortex Phellodendri, 17-26 parts of Fructus Cnidii, 20-22 parts of Senecio 13-17 parts of honeysuckle, 10-12 parts of forsythia, 17-19 parts of hibiscus bark, 22-27 parts of dandelion, 20-23 parts of white tinea bark, 20-22 parts of Kochia scoparia, 11-13 parts of camphor , 26-27 parts of Speranthum, 24-27 parts of Myrrh, 4-6 parts of chlorhexidine acetate, 10-20 parts of water-soluble polyethylene glycol succinimide succinate and trilysine acetate 2 to 4 servings.

Embodiment 2

[0045] A medicament for treating onychomycosis, comprising the following components: 22 parts of Salvia miltiorrhiza, 15 parts of Fangfeng, 12 parts of Baibu, 20 parts of Cortex Phellodendri, 17 parts of Fructus Cnidii, 20 parts of Senecio, 13 parts of honeysuckle, 10 parts of Forsythia, soil 17 parts of hibiscus bark, 22 parts of dandelion, 20 parts of white tinea bark, 20 parts of Kochia scoparia, 11 parts of camphor, 26 parts of Sperancus, 24 parts of myrrh, 4 parts of chlorhexidine acetate, water-soluble polyethylene glycol amber 10 parts imide succinate and 2 parts trilysine acetate.

Embodiment 3

[0047] A medicament for treating onychomycosis, comprising the following components: 25 parts of Salvia miltiorrhiza, 27 parts of Fangfeng, 16 parts of Baibu, 30 parts of Cortex Phellodendri, 26 parts of Fructus Cnidii, 22 parts of Senecio, 17 parts of honeysuckle, 12 parts of Forsythia, soil 19 parts of hibiscus bark, 27 parts of dandelion, 23 parts of white tinea bark, 22 parts of Kochia scoparia, 13 parts of camphor, 27 parts of Speranthema, 27 parts of myrrh, 6 parts of chlorhexidine acetate, water-soluble polyethylene glycol amber 20 parts imide succinate and 4 parts trilysine acetate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses medicine for treating onychomycosis. The medicine for treating onychomycosis comprises the following ingredients: 22 to 25 parts of radix salviae miltiorrhizae, 15 to 27 partsof radix sileris, 12 to 16 parts of radix stemonae, 20 to 30 parts of cortex phellodendri, 17 to 26 parts of fructus cnidiif, 20 to 22 parts of climbing groundsel, 13 to 17 parts of honeysuckle flowers, 10 to 12 parts of fructus forsythiae, 17 to 19 parts of cortex pseudolaricis, 22 to 27 parts of dandelion, 20 to 23 parts of cortex dictamni radicis, 20 to 22 parts of belvedere fruits, 11 to 13 parts of camphor, 26 to 27 parts of garden balsam stems, 24 to 27 parts of myrrh, 4 to 6 parts of chlorhexidine acetate, 10 to 20 parts of water-soluble polyethylene glycol disuccinimidyl succinate and2 to 4 parts of trilysine acetate. The invention also discloses a preparation method of the medicine for treating onychomycosis. Compared with the prior art, the medicine for treating onychomycosis provided by the invention has the advantages that the treatment is thorough, and the side effects are small.

Description

technical field [0001] The invention relates to a medicament for treating onychomycosis, in particular to a medicament for treating onychomycosis and a preparation method thereof. Background technique [0002] Onychomycosis, commonly known as "onychomycosis", refers to a disease caused by dermatophytes invading the nail plate or under the nail. Onychomycosis is a nail infection caused by fungi such as dermatophytes, yeasts, and nondermatophytes. Onychomycosis common has two kinds: 1. fungal leuconychia (superficial white onychomycosis), this type lesion is limited to a piece of nail surface or its tip; End subungual type and superficial white type, this type of lesion starts from the two sides or the distal end of the nail, and then the infection occurs under the nail plate. [0003] In order to treat onychomycosis, the technical scheme commonly used in the prior art has following several: [0004] Chinese patent application 201611015568.6 discloses a medicament for treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/904A61K47/18A61P17/00A61P31/10A61P29/00B01D11/02B02C18/06A61K31/155A61K31/125
CPCA61K9/0014A61K31/125A61K31/155A61K36/15A61K36/185A61K36/234A61K36/238A61K36/28A61K36/288A61K36/328A61K36/355A61K36/47A61K36/537A61K36/634A61K36/75A61K36/756A61K36/904A61K47/18A61K47/183A61K2236/331A61P17/00A61P29/00A61P31/10B01D11/0257B02C18/06A61K2300/00
Inventor 谭喜
Owner 湖南巨禧医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap